Vertical Wellness™ Acquires Tech-Holdings To Expand Proprietary Health and Wellness Hemp CBD Offerings Through Patented Technology And Brands
July 22nd, 2020
LOS ANGELES, July 22, 2020 /PRNewswire/ — Vertical Wellness™ [VWEL], an industry leader in the branded Hemp cannabinoid health and wellness space, acquired the assets of Tech-Holdings and various affiliates for between $5 and $10 million in debt, equity and earnout. No other financial details were disclosed.
Smoke Wallin, Chairman and CEO of Vertical Wellness said, “The team at Tech-Holdings, led by Steven Trenk, Tony Alfiere, and Ed Abel have accomplished what few in the industry have even thought of doing –they invented and patented novel ways of delivering cannabinoid ingredients that make them more effective and faster acting for medical ailments and conditions, within minutes, not hours. This is a game changer and will help us differentiate our brands from the rest of the market that mostly have no or limited science to their formulations. I welcome them to our growing team.”
Steven Trenk, founder & CEO of Tech-Holdings, and a long-time ArcView member and extensive investor in the cannabis space said, “We are delighted to bring our proprietary patented technology to Vertical Wellness. We talked to many of the largest players in the hemp and cannabis space in coming to our decision to join the Vertical team. Smoke’s vision for a vertically integrated consumer-focused health and wellness brand company, utilizing cannabinoid ingredients to help with insomnia, anxiety and pain as well as general health and wellness, resonated strongly with our team and investors.”
The combination enables a comprehensive line of unique, proprietary, fast acting products to address the needs of consumers in every demographic, geographic and economic segment of the marketplace. The patented technology enables Vertical Wellness to build on its relationships with its world class partners, including its kathy ireland® Worldwide partnership, by creating proprietary products with high efficacy in the health, wellness and beauty segments of the market.
“We are very much looking forward to launching our CBD Hemp brands with Vertical Wellness,” says Kathy Ireland, Chair, CEO and Chief Designer of kiWW®, and Vertical Wellness Advisory Board member who is named among the top ten women’s health advocates in America, according to UCLA. “We are committed to bringing our customers the most cutting-edge and highest quality products and incorporating Tech-Holdings patented technology into our products helps to truly differentiate them in the market.”
The initial releases are topical products including lotions for relief of pain and inflammation, day and night eye care, facial treatments and hand relief and includes Tech-Holdings proprietary brands, The Gold Q™ and AntiDos™.
About Vertical Wellness™
Vertical Wellness is a leading vertically integrated consumer focused health and wellness brand company with innovative Hemp cannabinoid solutions. Our mission is to help people by bringing the most innovative and effective portfolio of cannabinoid (CBD and others) brands to the market. Initial VWEL brands include kathy ireland® Health & Wellness, Taos™, Lap Dog™, Par5™, Halogenix™, Wingra Farms™, Neutrate™, USMCC™, and Hemp-Moji™. VWEL Services™ leverages our extensive investment and team knowledge by helping the entire industry with strategic, financial, branding, sales and hemp processing solutions. Vertical Wellness has operations in California and Kentucky and cultivated over 1,800 acres of hemp on partner farms in 2019. The Company is one of the largest processors of Hemp globally with close to 20 million lbs processed or contracted in 2020.
Tech-Holdings is a technology focused cannabinoid (CBD and others) research and development company. One of the early R&D investors in cannabinoid ingredient efficacy and delivery methods, Tech-Holdings developed a body of Intellectual Property “IP” around cannabinoid delivery that make products more effective (higher bioavailability) and faster acting. One of the primary advantages of products utilizing the patented delivery system is rapid diffusion of lipid molecules across the epithelium and into the bloodstream bypassing first-pass liver processing. A second advantage is increased efficiency of absorption. The limited absorption and diffusion profiles of most of the current products in the market fail to deliver cannabinoids across the epithelium or the upper GI tract. This limits absorption to the intestine, thus subjecting all cannabinoids to first-pass liver processing which may reduce effectiveness. Tech-Holdings technology provides for rapid diffusion both across the epithelium and into the bloodstream to efficiently deliver beneficial molecules. It also enables the production of cannabinoid enriched powders that easily mix with water allowing for the development of fast-acting topicals/targeted cosmetics and a wide variety of edible/consumable products.
SOURCE Vertical Wellness and Tech-Holdings
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.